Stem cells offer tremendous promise for advancing health and medicine. Whether being used to replace damaged cells and organs or else by supporting the body’s intrinsic repair mechanisms, stem cells hold the potential to treat such debilitating conditions as Parkinson’s disease, diabetes, and spinal cord injury. Clinical trials of stem cell treatments are under way in countries around the world, but the evidence base to support the medical use of stem cells remains limited. Despite this paucity of clinical evidence, consumer demand for treatments using stem cells has risen, driven in part by a lack of available treatment options for debilitating diseases as well as direct-to-consumer advertising and public portrayals of stem cell-based treatments. Clinics that offer stem cell therapies for a wide range of diseases and conditions have been established throughout the world, both in newly industrialized countries such as China, India, and Mexico and in developed countries such as the United States and various European nations. Though these therapies are often promoted as being established and effective, they generally have not received stringent regulatory oversight and have not been tested with rigorous trials designed to determine their safety and likely benefits. In the absence of substantiated claims, the potential for harm to patients – as well as to the field of stem cell research in general – may outweigh the potential benefits.
To explore these issues, the Institute of Medicine, the National Academy of Sciences, and the International Society for Stem Cell Research held a workshop in November 2013. Stem Cell Therapies summarizes the workshop. Researchers, clinicians, patients, policy makers, and others from North America, Europe, and Asia met to examine the global pattern of treatments and products being offered, the range of patient experiences, and options to maximize the well-being of patients, either by protecting them from treatments that are dangerous or ineffective or by steering them toward treatments that are effective. This report discusses the current environment in which patients are receiving unregulated stem cell offerings, focusing on the treatments being offered and their risks and benefits. The report considers the evidence base for clinical application of stem cell technologies and ways to assure the quality of stem cell offerings.
THE ONLY TRUE PLANT STEM CELL THERAPY: Plant Stem Cell Beauty/Cambial Meristematic Immortal Cells (CMC Korean Anti-Aging serum contains the secrets of imported Korean beauty that uses immortal plant stem (meristematic) cells from the wild ginseng plant; our active & immortal cells can self-renew. The cells provide your skin with restorative cells for immediate anti-aging skin restoration
ANTI-AGING: Our Korean scientists developed a unique way to extract the ginseng plant’s stem cells (PSC). The Plant Stem Cell anti-aging serum helps improve: skin texture, restoring skin tone, rebuilds elasticity of the skin, repairs damaged collagen, reduces deep & fine skin lines, and skin firmness
HOW ARE WE UNIQUE? Other brands use “stem like” but not true stem cells. The meristematic cells used in our Plant Stem Cell Beauty’s restoration serum are true & active cells. This allows for ultimate skin results: increased collagen, face lifting, repair of damaged skin cells/free radicals, maximized moisture absorption, & increased skin cell fibers for greater elasticity
REVOLUTIONARY SCIENCE: Plant Stem Cell Beauty Anti-Aging Serums Wild Ginseng stem cell is the world’s first skin repair plant stem cell serum that uses plants stem cells successfully isolated and cultured to restore your skin on an unprecedented level; the results are that your skin will look healthier and you will look younger in 6 weeks
SAVE 20% & LOOK YOUNGER IN 6 WEEKS: Want skin irritation relief, in-depth moisturization, and anti-aging protection all in one? Save 20% with our Plant Stem Cell Beauty Rejuvenation Collection (cream, serum, & mask)
This invaluable resource discusses clinical applications with effects and side-effects of applications of stem cells in bone and cartilage regeneration. Each chapter is contributed by a pre-eminent scientist in the field and covers such topics as skeletal regeneration by mesenchymal stem cells, clinical improvement of mesenchymal stem cell injection in injured cartilage and osteoarthritis, Good manufacturing practice (GMP), minimal critera of stem cells for clinical applications, future directions of the discussed therapies and much more. Bone & Cartilage Regeneration and the other books in the Stem Cells in Clinical Applications series will be invaluable to scientists, researchers, advanced students and clinicians working in stem cells, regenerative medicine or tissue engineering.